Skip to main content

Advertisement

SpringerLink
Log in

Rickets, elevated fibroblast growth factor-23 and mild anemia: Answers

  • Clinical Quiz
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tiosano D, Hochberg Z (2009) Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab 27:392–401

    Article  Google Scholar 

  2. Penido MG, Alon US (2014) Hypophosphatemic rickets due to perturbations in renal tubular function. Pediatr Nephrol 29:361–373

    Article  Google Scholar 

  3. Alon US (2011) Fibroblast growth factor (FGF)23: a new hormone. Eur J Pediatr 170:545–554

    Article  CAS  Google Scholar 

  4. Eyskens B, Proesmans W, Damme V, Lauter L, Bouillon R, Hoogmarten M (1995) Tumor-induced rickets: a case report and review of the literature. Eur J Pediatr 154:462–464

    Article  CAS  Google Scholar 

  5. Holm IA, Econs MJ, Carpenter TO (2012) Familial hypophosphatemia and related disorders. In: Glorieux FH, Pettifor JM, Juppner H (eds) Pediatric bone, 2nd edn. Elsevier, Amsterdam, pp 699–726

    Chapter  Google Scholar 

  6. Bitzan M, Goodyer PR (2019) Hypophosphatemic rickets. Pediatr Clin North Am 66:179–207. https://doi.org/10.1016/j.pcl.2018.09.004

    Article  PubMed  Google Scholar 

  7. Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, Econs MJ (2011) Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metab 96:3541–3549. https://doi.org/10.1210/jc.2011-1239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Liu C, Li X, Zhao Z, Chi Y, Cui L, Zhang Q, Ping F, Chai X, Jiang Y, Wang O, Li M, Xing X, Xia W (2020) Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets. Osteoporos Int. https://doi.org/10.1007/s00198-020-05649-w

  9. Winters RW, Graham JB, Williams TF, McFalls VW, Burnett CH (1991) A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature. 1958. Medicine (Baltimore) 70:215–217

    Article  CAS  Google Scholar 

  10. Eicher EM, Southard JL, Scriver CR, Glorieux FH (1976) Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci U S A 73:4667–4671. https://doi.org/10.1073/pnas.73.12.4667

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Högler W, Kapelari K (2020) Oral iron for prevention and treatment of rickets and osteomalacia in autosomal dominant hypophosphatemia. J Bone Miner Res 35:226–230. https://doi.org/10.1002/jbmr.3941

    Article  CAS  PubMed  Google Scholar 

  12. Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305–1315. https://doi.org/10.1681/ASN.2005111185

    Article  CAS  PubMed  Google Scholar 

  13. Bielesz B, Reiter T, Hammerle FP, Winnicki W, Bojic M, Gleiss A, Kieweg H, Ratzinger F, Sunder-Plassmann G, Marculescu R (2020) The role of iron and erythropoietin in the association of fibroblast growth factor 23 with anemia in chronic kidney disease in humans. J Clin Med 9:2640. https://doi.org/10.3390/jcm9082640

    Article  CAS  PubMed Central  Google Scholar 

  14. Komaba H, Fukagawa M (2012) The role of FGF23 in CKD—with or without Klotho. Nat Rev Nephrol 8:484–490. https://doi.org/10.1038/nrneph.2012.116

    Article  CAS  PubMed  Google Scholar 

  15. Francis C, Courbon G, Gerber C, Neuburg S, Wang X, Dussold C, Capella M, Qi L, Isakova T, Mehta R, Martin A, Wolf M, David V (2019) Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease. Kidney Int 96:1346–1358. https://doi.org/10.1016/j.kint.2019.07.026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the family for giving us the permission to publish the case.

Author information

Authors and Affiliations

  1. Bone and Mineral Disorders Clinic, Division of Pediatric Nephrology, The Children’s Mercy Hospital, University of Missouri - Kansas City School of Medicine, 2401 Gillham Road, Kansas City, MO, 64108, USA

    Judith Sebestyen VanSickle, Tarak Srivastava, Penny Monachino & Uri S. Alon

Authors
  1. Judith Sebestyen VanSickle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tarak Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Penny Monachino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Uri S. Alon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Judith Sebestyen VanSickle.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This refers to the article that can be found at https://doi.org/10.1007/s00467-021-05000-3.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

VanSickle, J.S., Srivastava, T., Monachino, P. et al. Rickets, elevated fibroblast growth factor-23 and mild anemia: Answers. Pediatr Nephrol 36, 2301–2304 (2021). https://doi.org/10.1007/s00467-021-05012-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-021-05012-z

Keywords

Search

Navigation